Administrative/Regulatory
Dec. 10, 2010
First Diet Drug in Years Nears Approval
An FDA advisory committee recommended on Tuesday that the agency give final approval by Jan. 31 to the drug Contrave, developed by San Diego-based Orexigen Therapeutics Inc., after the regulator shot down two other California companies' diet drugs.
Daily Journal Staff Writer
The first new prescription diet drug in 13 years is on the brink of approval by the U.S. Food and Drug Administration next month.
An FDA advisory committee recommended late Tuesday that the agency approve Contrave, developed by San Diego-based Orexigen Therapeutics Inc., after the panel shot down two other California companies' diet drugs.
The Endocrinologic and Metabolic Drugs Advisory...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In